ACHE and schizophrenia: Interestingly, a Cochrane review of clinical randomised trials revealed that the addition of acetylcholinesterase inhibitors to antipsychotics leads to improvements in the overall psychopathology, negative symptomatology, and depressive symptoms in individuals diagnosed with schizophrenia [87].